Department of Drug Design and Pharmacology, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
ChemMedChem. 2012 Oct;7(10):1808-14. doi: 10.1002/cmdc.201200335. Epub 2012 Aug 27.
Na(+)-coupled HCO(3)(-) transporters (NBCs) mediate the transport of bicarbonate ions across cell membranes and are thus ubiquitous regulators of intracellular pH. NBC dysregulation is associated with a range of diseases; for instance, NBCn1 is strongly up-regulated in a model of ErbB2-dependent breast cancer, a malignant and widespread cancer with no targeted treatment options, and single-nucleotide polymorphisms in NBCn1 genetically link to breast cancer development and hypertension. The N-cyanosulfonamide S0859 has been shown to selectively inhibit NBCs, and its availability on the gram scale is therefore of significant interest to the scientific community. Herein we describe a short and efficient synthesis of S0859 with an overall yield of 45 % from commercially available starting materials. The inhibitory effect of S0859 on recovery of intracellular pH after an acid load was verified in human and murine cancer cell lines in Ringer solutions. However, S0859 binds very strongly to components in plasma, and accordingly, measurements on isolated murine tissues showed no effect of S0859 at concentrations up to 50 μM.
钠(+)-偶联的 HCO3(-)转运体(NBCs)介导碳酸氢根离子跨细胞膜的转运,因此是细胞内 pH 的普遍调节剂。NBC 的失调与一系列疾病有关;例如,在 ErbB2 依赖性乳腺癌模型中,NBCn1 强烈上调,这是一种恶性且广泛存在的癌症,没有靶向治疗选择,而 NBCn1 中的单核苷酸多态性与乳腺癌发展和高血压有关。已证明 N-氰基磺酰胺 S0859 可选择性抑制 NBCs,因此其在克级规模上的可用性引起了科学界的极大兴趣。本文描述了一种从商业上可获得的起始原料合成 S0859 的短而有效的方法,总收率为 45%。在 Ringer 溶液中,用人和鼠癌细胞系验证了 S0859 对酸负荷后细胞内 pH 恢复的抑制作用。然而,S0859 与血浆中的成分结合非常牢固,因此,在高达 50 μM 的浓度下,对分离的鼠组织的测量显示 S0859 没有作用。